Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women.

Gao H, Meng J, Xing H, Nie S, Xu M, Zhang S, Jin Y, Sun T, Huang H, Zhang H, Wang D, Liu L.

Hum Reprod. 2014 May;29(5):1058-66. doi: 10.1093/humrep/deu029.

2.
3.
4.

Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.

Kim JJ, Chae SJ, Choi YM, Hwang KR, Song SH, Yoon SH, Kim SM, Ku SY, Kim SH, Kim JG, Moon SY.

Hum Reprod. 2013 May;28(5):1354-60. doi: 10.1093/humrep/det057.

5.

Association of serum levels of typical organic pollutants with polycystic ovary syndrome (PCOS): a case-control study.

Yang Q, Zhao Y, Qiu X, Zhang C, Li R, Qiao J.

Hum Reprod. 2015 Aug;30(8):1964-73. doi: 10.1093/humrep/dev123.

6.

Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.

Sam S, Scoccia B, Yalamanchi S, Mazzone T.

Hum Reprod. 2015 Jun;30(6):1358-64. doi: 10.1093/humrep/dev073.

7.

Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.

Mumm H, Altinok ML, Henriksen JE, Ravn P, Glintborg D, Andersen M.

Hum Reprod. 2016 May;31(5):1105-12. doi: 10.1093/humrep/dew046.

PMID:
27008892
8.

Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.

Rees E, Coulson R, Dunstan F, Evans WD, Blundell HL, Luzio SD, Dunseath G, Halcox JP, Fraser AG, Rees DA.

Hum Reprod. 2014 Sep;29(9):2041-9. doi: 10.1093/humrep/deu180.

9.

Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.

Zhang J, Fan P, Liu H, Bai H, Wang Y, Zhang F.

Hum Reprod. 2012 Aug;27(8):2484-93. doi: 10.1093/humrep/des191.

10.

Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.

Tziomalos K, Katsikis I, Papadakis E, Kandaraki EA, Macut D, Panidis D.

Hum Reprod. 2013 Mar;28(3):785-93. doi: 10.1093/humrep/des456.

11.

Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.

Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ.

Hum Reprod. 2013 Mar;28(3):777-84. doi: 10.1093/humrep/des463.

12.

The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.

Yang HY, Ma Y, Lu XH, Liang XH, Suo YJ, Huang ZX, Lu DC, Qin YF, Luo ZJ.

Ann Endocrinol (Paris). 2015 Oct;76(5):620-7. doi: 10.1016/j.ando.2015.08.002.

PMID:
26514948
13.
14.

Young women with polycystic ovary syndrome have raised levels of circulating annexin V-positive platelet microparticles.

Willis GR, Connolly K, Ladell K, Davies TS, Guschina IA, Ramji D, Miners K, Price DA, Clayton A, James PE, Rees DA.

Hum Reprod. 2014 Dec;29(12):2756-63. doi: 10.1093/humrep/deu281.

15.

Myostatin and its association with abdominal obesity, androgen and follistatin levels in women with polycystic ovary syndrome.

Chen MJ, Han DS, Yang JH, Yang YS, Ho HN, Yang WS.

Hum Reprod. 2012 Aug;27(8):2476-83. doi: 10.1093/humrep/des209.

16.

Expression levels of haem oxygenase-1 in the omental adipose tissue and peripheral blood mononuclear cells of women with polycystic ovary syndrome.

Seow KM, Lin YH, Hwang JL, Wang PH, Ho LT, Lin YH, Juan CC.

Hum Reprod. 2011 Feb;26(2):431-7. doi: 10.1093/humrep/deq351.

17.

Association between circulating adiponectin levels and polycystic ovarian syndrome.

Mirza SS, Shafique K, Shaikh AR, Khan NA, Anwar Qureshi M.

J Ovarian Res. 2014 Feb 7;7:18. doi: 10.1186/1757-2215-7-18.

18.

Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.

Glintborg D, Altinok M, Mumm H, Buch K, Ravn P, Andersen M.

Hum Reprod. 2014 Aug;29(8):1773-9. doi: 10.1093/humrep/deu133.

19.

A prediction model to select PCOS patients suitable for IVM treatment based on anti-Mullerian hormone and antral follicle count.

Guzman L, Ortega-Hrepich C, Polyzos NP, Anckaert E, Verheyen G, Coucke W, Devroey P, Tournaye H, Smitz J, De Vos M.

Hum Reprod. 2013 May;28(5):1261-6. doi: 10.1093/humrep/det034.

20.

Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.

Daan NM, Jaspers L, Koster MP, Broekmans FJ, de Rijke YB, Franco OH, Laven JS, Kavousi M, Fauser BC.

Hum Reprod. 2015 Oct;30(10):2376-86. doi: 10.1093/humrep/dev195.

Items per page

Supplemental Content

Support Center